143 related articles for article (PubMed ID: 9626661)
1. Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor.
Couette B; Jalaguier S; Hellal-Levy C; Lupo B; Fagart J; Auzou G; Rafestin-Oblin ME
Mol Endocrinol; 1998 Jun; 12(6):855-63. PubMed ID: 9626661
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.
Couette B; Fagart J; Jalaguier S; Lombes M; Souque A; Rafestin-Oblin ME
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):421-7. PubMed ID: 8615809
[TBL] [Abstract][Full Text] [Related]
3. Putative steroid binding domain of the human mineralocorticoid receptor, expressed in E. coli in the presence of heat shock proteins shows typical native receptor characteristics.
Jaglaguier S; Mesnier D; Láger JL; Auzou G
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):43-50. PubMed ID: 8645616
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.
Hellal-Levy C; Fagart J; Souque A; Wurtz JM; Moras D; Rafestin-Oblin ME
Mol Endocrinol; 2000 Aug; 14(8):1210-21. PubMed ID: 10935545
[TBL] [Abstract][Full Text] [Related]
5. New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding.
Sartorato P; Cluzeaud F; Fagart J; Viengchareun S; Lombès M; Zennaro MC
Mol Endocrinol; 2004 Sep; 18(9):2151-65. PubMed ID: 15192075
[TBL] [Abstract][Full Text] [Related]
6. Distinct functions of the 90 kDa heat-shock protein (hsp90) in oestrogen and mineralocorticosteroid receptor activity: effects of hsp90 deletion mutants.
Binart N; Lombès M; Baulieu EE
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):797-804. PubMed ID: 7487934
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of ligand binding to the mineralocorticoid receptor.
Huyet J; Pinon GM; Fay MR; Rafestin-Oblin ME; Fagart J
Mol Cell Endocrinol; 2012 Mar; 350(2):187-95. PubMed ID: 21820032
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic aspects of mineralocorticoid receptor activation.
Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
Kidney Int; 2000 Apr; 57(4):1250-5. PubMed ID: 10760050
[TBL] [Abstract][Full Text] [Related]
9. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
10. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
Dey R; Roychowdhury P
J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
[TBL] [Abstract][Full Text] [Related]
11. Dual roles of 90-kDa heat shock protein in the function of the mineralocorticoid receptor.
Nemoto T; Ohara-Nemoto Y; Sato N; Ota M
J Biochem; 1993 Jun; 113(6):769-75. PubMed ID: 8396573
[TBL] [Abstract][Full Text] [Related]
12. Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor.
Souque A; Fagart J; Couette B; Rafestin-Oblin ME
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):315-21. PubMed ID: 8639467
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
Zennaro MC; Le Menuet D; Lombès M
Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
[TBL] [Abstract][Full Text] [Related]
14. Novel interactions of the mineralocorticoid receptor.
Fuller PJ
Mol Cell Endocrinol; 2015 Jun; 408():33-7. PubMed ID: 25662276
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.
Jalaguier S; Lupo B; Hugon G; Rafestin-Oblin ME; Auzou G
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):57-63. PubMed ID: 9164841
[TBL] [Abstract][Full Text] [Related]
16. Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity.
Gallo LI; Ghini AA; Piwien Pilipuk G; Galigniana MD
Biochemistry; 2007 Dec; 46(49):14044-57. PubMed ID: 18001136
[TBL] [Abstract][Full Text] [Related]
17. Antagonism in the human mineralocorticoid receptor.
Fagart J; Wurtz JM; Souque A; Hellal-Levy C; Moras D; Rafestin-Oblin ME
EMBO J; 1998 Jun; 17(12):3317-25. PubMed ID: 9628869
[TBL] [Abstract][Full Text] [Related]
18. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors.
Rogerson FM; Yao YZ; Elsass RE; Dimopoulos N; Smith BJ; Fuller PJ
Mol Endocrinol; 2007 Apr; 21(4):817-28. PubMed ID: 17284665
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping.
Trapp T; Holsboer F
Biochem Biophys Res Commun; 1995 Oct; 215(1):286-91. PubMed ID: 7575603
[TBL] [Abstract][Full Text] [Related]
20. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding.
Lupo B; Mesnier D; Auzou G
Biochemistry; 1998 Sep; 37(35):12153-9. PubMed ID: 9724527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
